Evaluation of cell-penetrating peptides (CPPs) as vehicles for intracellular delivery of antisense peptide nucleic acid (PNA)

Bioconjugate Chemistry

Volumn 17, Issue 3, 2006, Pages 750-758

  Bendifallah, Nadia ^a   Rasmussen, Frank Winther ^b,d   Zachar, Vladimir ^c   Ebbesen, Peter ^c   Nielsen, Peter E ^a,b,d   Koppelhus, Uffe ^a,c  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b Santaris Pharma AS   (Denmark)

^c AALBORG UNIVERSITY   (Denmark)

^d NOVOZYMES A S   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACIDS; BODY FLUIDS; GENE EXPRESSION; MAMMALS; NUCLEIC ACIDS; SULFUR COMPOUNDS; SYNTHESIS (CHEMICAL);

ANTISENSE PEPTIDES; CELL-PENETRATING PEPTIDE; INTRACELLULAR DELIVERY; LUCIFERASE GENES; MAMMALIAN CELLS; NUCLEIC ACID OLIGOMERS; OLIGOARGININE; PENETRATIN; PEPTIDE NUCLEIC ACID; RELATIVE POTENCIES;

PEPTIDES;

ANTISENSE PEPTIDE NUCLEIC ACID; CELL PENETRATING PEPTIDE; DRUG CARRIER; DRUG VEHICLE; ESTER; LYSYLPHENYLALANYLPHENYLALANINE; MALEIMIDE; NLS PEPTIDE; OLIGOARGININE; OLIGOMER; PENETRATIN; PEPTIDE; PEPTIDE NUCLEIC ACID; PTAT PEPTIDE; SYNB3 PEPTIDE; TRANSPORTAN; UNCLASSIFIED DRUG;

ARTICLE; CONJUGATION; CONTROLLED STUDY; CULTURE MEDIUM; DISULFIDE BOND; DRUG DELIVERY SYSTEM; DRUG TRANSPORT; EVALUATION; HUMAN; HUMAN CELL; INTERNALIZATION; LUCIFERASE GENE; MAMMAL CELL; PEPTIDE SYNTHESIS; RECOMBINANT GENE;

MAMMALIA;

EID: 33646950391     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc050283q     Document Type: Article

References (35)

1. Jarver, P., Langel, U. (2004) The use of cell-penetrating peptides as a tool for gene regulation. Drug Discov Today 9, 395-402.
2. Moulton, H. M., Nelson, M. H., Hatlevig, S. A., Reddy, M. T., and Iversen, P. L. (2004) Cellular uptake of antisense morpholino oligomers conjugated to arginine-rich peptides. Bioconjugate Chem. 15, 290-299.
3. Pooga, M., Kut, C., Kihlmark, M., Hallbrink, M., Fernaeus, S., Raid, R., Land, T., Hallberg, E., Bartfai, T., and Langel, U. (2001) Cellular translocation of proteins by transportan. FASEB J. 15, 1451-1453.
4. Terrone, D., Sang, S. L., Roudaia, L., and Silvius, J. R. (2003) Penetratin and related cell-penetrating cationic peptides can translocate across lipid bilayers in the presence of a transbilayer potential. Biochemistry 42, 13787-13799.
5. Thoren, P. E., Persson, D., Isakson, P., Goksor, M., Onfelt, A., and Norden, B. (2003) Uptake of analogs of penetratin, Tat(48-60) and oligoarginine in live cells. Biochem. Biophys. Res. Commun. 307, 100-107.
6. Trehin, R., and Merkle, H. P. (2004) Chances and pitfalls of cell penetrating peptides for cellular drug delivery. Eur. J. Pharm. Biopharm. 58, 209-223.
7. Vives, E. (2003) Cellular uptake [correction of utake] of the Tat peptide: an endocytosis mechanism following ionic interactions. J. Mol. Recognit. 16, 265-271.
8. Prochiantz, A. (1999) Homeodomain-derived peptides. In and out of the cells. Ann. N. Y. Acad. Sci. 886, 172-179.
9. Derossi, D., Chassaing, G., and Prochiantz, A. (1998) Trojan peptides: the penetratin system for intracellular delivery. Trends Cell Biol. 8, 84-87.
10. Oehlke, J., Scheller, A., Wiesner, B., Krause, E., Beyermann, M., Klauschenz, E., Melzig, M., and Bienert, M. (1998) Cellular uptake of an alpha-helical amphipathic model peptide with the potential to deliver polar compounds into the cell interior non-endocytically. Biochim. Biophys. Acta 1414, 127-139.
11. Koppelhus, U., Awasthi, S. K., Zachar, V., Holst, H. U., Ebbesen, P., and Nielsen, P. E. (2002) Cell-dependent differential cellular uptake of PNA, peptides, and PNA-peptide conjugates. Antisense Nucleic Acid Drug Dev. 12, 51-63.
12. Ross, M. F., Filipovska, A., Smith, R. A., Gait, M. J., and Murphy, M. P. (2004) Cell-penetrating peptides do not cross mitochondrial membranes even when conjugated to a lipophilic cation: evidence against direct passage through phospholipid bilayers. Biochem. J. 383, 457-468.
13. Richard, J. P., Melikov, K., Vives, E., Ramos, C., Verbeure, B., Gait, M. J., Chernomordik, L. V., and Lebleu, B. (2003) Cell-penetrating peptides. A reevaluation of the mechanism of cellular uptake. J. Biol. Chem. 278, 585-590.
14. Ziegler, A., Nervi, P., Durrenberger, M., and Seelig, J. (2005) The cationic cell-penetrating peptide CPP(TAT) derived from the HIV-1 protein TAT is rapidly transported into living fibroblasts: optical, biophysical, and metabolic evidence. Biochemistry 44, 138-148.
15. Thoren, P. E., Persson, D., Esbjorner, E. K., Goksor, M., Lincoln, P., and Norden, B. (2004) Membrane binding and translocation of cell-penetrating peptides. Biochemistry 43, 3471-3489.
16. Hallbrink, M., Floren, A., Elmquist, A., Pooga, M., Bartfai, T., and Langel, U. (2001) Cargo delivery kinetics of cell-penetrating peptides. Biochim. Biophys. Acta 1515, 101-109.
17. Saalik, P., Elmquist, A., Hansen, M., Padari, K., Saar, K., Viht, K., Langel, U., and Pooga, M. (2004) Protein cargo delivery properties of cell-penetrating peptides. A comparative study. Bioconjugate Chem. 15, 1246-1253.
18. Astriab-Fisher, A., Sergueev, D., Fisher, M., Shaw, B. R., and Juliano, R. L. (2002) Conjugates of antisense oligonucleotides with the Tat and antennapedia cell-penetrating peptides: effects on cellular uptake, binding to target sequences, and biologic actions. Pharm. Res. 19, 744-754.
19. Moulton, H. M., and Moulton, J. D. (2004) Arginine-rich cell-penetrating peptides with uncharged antisense oligomers. Drug Discov. Today 9, 870.
20. Kang, S. H., Cho, M. J., and Kole, R. (1998) Up-regulation of luciferase gene expression with antisense oligonucleotides: implications and applications in functional assay development. Biochemistry 37, 6235-6239.
21. Shiraishi, T., and Nielsen, P. E. (2004) Down-regulation of MDM2 and activation of p53 in human cancer cells by antisense 9-aminoacridine-PNA (peptide nucleic acid) conjugates. Nucleic Acids Res. 32, 4893-4902.
22. Pooga, M., Soomets, U., Hallbrink, M., Valkna, A., Saar, K., Rezaei, K., Kahl, U., Hao, J. X., Xu, X. J., Wiesenfeld-Hallin, Z., Hokfelt, T., Bartfai, T., and Langel, U. (1998) Cell penetrating PNA constructs regulate galanin receptor levels and modify pain transmission in vivo. Nat. Biotechnol. 16, 857-861.
23. Koppelhus, U., and Nielsen, P. E. (2003) Cellular delivery of peptide nucleic acid (PNA). Adv Drug Deliv. Rev. 55, 267-280.
24. Good, L., Awasthi, S. K., Dryselius, R., Larsson, O., and Nielsen, P. E. (2001) Bactericidal antisense effects of peptide-PNA conjugates. Nat. Biotechnol. 19, 360-364.
25. Eriksson, M., Nielsen, P. E., and Good, L. (2002) Cell permeabilization and uptake of antisense peptide-peptide nucleic acid (PNA) into Escherichia coli. J. Biol. Chem. 277, 7144-7147.
26. Rousselle, C., Smirnova, M., Clair, P., Lefauconnier, J. M., Chavanieu, A., Calas, B., Scherrmann, J. M., and Temsamani, J. (2001) Enhanced delivery of doxorubicin into the brain via a peptide-vector-mediated strategy: saturation kinetics and specificity. J. Pharmacol. Exp. Ther. 296, 124-131.
27. Temsamani, J., Bonnafous, C., Rousselle, C., Fraisse, Y., Clair, P., Granier, L. A., Rees, A. R., Kaczorek, M., Scherrmann, J. M. (2005) Improved brain uptake and pharmacological activity profile of morphine-6-glucuronide using a peptide-vector-mediated strategy. J. Pharmacol. Exp. Ther. 313, 712-719.
28. Cutrona, G., Carpaneto, E. M., Ulivi, M., Roncella, S., Landt, O., Ferrarini, M., and Boffa, L. C. (2000) Effects in live cells of a c-myc anti-gene PNA linked to a nuclear localization signal. Nat. Biotechnol. 18, 300-303.
29. Chinnery, P. F., Taylor, R. W., Diekert, K., Lill, R., Turnbull, D. M., and Lightowlers, R. N. (1999) Peptide nucleic acid delivery to human mitochondria. Gene Ther. 6, 1919-1928.
30. Awasthi, S. K., and Nielsen, P. E. (2002) Synthesis of PNA-peptide conjugates. Methods Mol. Biol. 208, 43-52.
31. Bendifallah, N., Kristensen, E., Dahl, O., Koppelhus, U., and Nielsen, P. E. (2003) Synthesis and properties of ester-linked peptide nucleic acid prodrug conjugates. Bioconjugate Chem. 14, 588-592.
32. Rasmussen, F. W., Bendifallah, N., Zachar, V., Shiraishi, T., Fink, T., Ebbesen, P., Nielsen, P. E., and Koppelhus, U. (2006) Evaluation of transfection protocols for unmodified and modified peptide nucleic acid (PNA) oligomers. Oligonucleotides 16, 42-56.
33. Pichon, C., Monsigny, M., and Roche, A. C. (1999) Intracellular localization of oligonucleotides: influence of fixative protocols. Antisense Nucleic Acid Drug Dev. 9, 89-93.
34. Knudsen, H., and Nielsen, P. E. (1996) Antisense properties of duplex- and triplex-forming PNAs. Nucleic Acids Res. 24, 494-500.
35. Koppelhus, U., Zachar, V., Nielsen, P. E., Liu, X., Eugen-Olsen, J., and Ebbesen, P. (1997) Efficient in vitro inhibition of HIV-1 gag reverse transcription by peptide nucleic acid (PNA) at minimal ratios of PNA/RNA. Nucleic Acids Res. 25, 2167-2173.